TCM
ROIV icon

Tang Capital Management’s Roivant Sciences ROIV Stock Holding History

Tang Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-101,404
Closed -$413K – 97
2022
Q2 		$413K Buy
+101,404
New +$403K 0.06% 66

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Tang Capital Management's ROIV Position: Q3 2022 in Review

Tang Capital Management sold out of Roivant Sciences (ROIV) in Q3 2022, closing a stake of 101,404 shares — an estimated $413K sold.

Tang Capital Management first reported a position in ROIV in Q2 2022 and held it in 1 quarter. The position peaked at $413K in Q2 2022. 78 funds tracked by Wall St. Rank hold ROIV as of Q3 2022.

  • Tang Capital Management reported no remaining Roivant Sciences position as of Q3 2022 after selling out during the quarter.
  • Tang Capital Management sold 101,404 Roivant Sciences shares in Q3 2022, an estimated $413K.
  • Tang Capital Management first reported a position in Roivant Sciences in Q2 2022 and held it in 1 quarter.
  • Tang Capital Management's Roivant Sciences position peaked at $413K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2022.

Based on Tang Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.